top of page

This really is India's time says Aubrey Capital Management

When it comes to the "big" emerging markets, and by that we mean big by both population and potential, it was a rather binary year in 2021, says Rob Brewis, fund manager for the Aubrey Global Emerging Market strategy.

China down 20% and India up 20%. It would be easy to say that 2022 will be another reversal of fortunes, a little like 2021 was a reversal of 2020. We have some sympathy with that view.

China had such a "good" early covid experience in 2020, both controlling the pandemic internally and enjoying an export boom in all the things we needed while stuck at home. . It was always going to be a hard act to follow. And so it proved.

"2022 will certainly be no different, find the right companies, and it should be a rewarding year."

The regulatory clampdown on the sectors that had become the poster children of both Chinese innovation and its stock market clearly undermined some business models and adversely affected sentiment towards others.

A tight noose on economic policy continued, as the CCP tried hard to curtail unwanted leverage in local governments and property developers.

And finally, valuations were elevated, especially in those more technology orientated sectors.

Looking into 2022 it is easy to make the case that all these headwinds will at least subside, if not reverse. Comparisons will be easier for a start.

The regulatory issues might not be going away, but it is hard to see them having anything like the impact of the past year. Any proclamations or fines these days are generally met with a shrug. The indications are that Beijing will be easing policy at the margin in 2022, and valuations have corrected a great deal and look highly attractive in most cases.

India, in contrast, stuttered with the first covid wave in 2020 but soon realised the futility of lockdowns in a country at India's stage of development. The second wave was brutal from an immediate human point of view, but letting it run has perhaps saved many more lives as natural immunity has now kicked in. Since then, the economy has roared back, as if making up for lost time. More likely, it is getting back to a higher growth setting which has been made possible by the significant, and perhaps underappreciated, strides the country has made in recent years.

There are a multitude of reasons why we believe this really is India's time, and these have been discussed before, and will not be regurgitated here (much). These are mostly structural (better infrastructure, reduced corruption, lower inflation, urbanisation, financial inclusion and technology, booming manufacturing…), but are also cyclical (residential property upturn, low corporate leverage, potential investment cycle).

We could go on. But there is no doubt this has not gone unnoticed by the stock market, as reflected in this year's performance, and valuations are stretched, even by Indian standards.

We have reduced some exposure, but are reluctant to leave the dancefloor given the aforementioned potential. Growth is most likely to exceed expectations. It is also encouraging to see the field is broadening for us, with the listing of several new businesses in potentially attractive consumer focussed areas: Zomato (food delivery), Nykaa (e-commerce), Policy Bazaar (insurance comparison), PayTM (payments) to name a few.

Elsewhere in the Emerging Markets world it has been a very mixed bag, with country index returns ranging from over 30% gains (Czech Republic) to over 30% losses (Turkey). Of the big, more developed markets, Taiwan, despite the political backdrop, has won handsomely over Korea in 2021. Both of these are overly influenced by semiconductor behemoths, an area in which we do not claim expertise. That said, it is firmly our view that the talk of semiconductor shortages, or indeed any other shortages, will be a distant memory by this time next year.

In the rest of Asia our exposure remains largely through Sea Limited whose business has had another good year, albeit the stock price has corrected of late. We remain positive on the business and the shares now look attractive once more. As in India, the field here is widening with the listing of Bukalapak (e-commerce) and GRAB (ride hailing/delivery) and the imminent arrival of GoTo (the merger of Indonesian champions Gojek and Tokopedia). The more traditional areas of consumption remain hampered by lingering covid issues, indifferent politics, and competition from the online world.

Troubled politics and the associated hurt this causes economies and confidence can be extended beyond South East Asia, with potentially troublesome elections coming in Brazil next year, the primary reason for our recent exit. We retain selective and very stock specific exposure outwith the big markets of India and China, and while always on the hunt, do not see this changing markedly in 2022.

Our current stocks have a range of valuations but overall the portfolio is sitting a little above the typical 1x PEG ratio. It is worth remembering though that this is clearly distorted by the larger Indian weighting where valuations tend always to be higher.

The China holdings typically have lower PEGs, and particularly so now, and any move back into China would swing the portfolio PEG lower. What is more important to us is not so much what PE we pay, but in ensuring the growth is really coming through to justify it.

We do this by looking in the right areas, whether its electric vehicles in China, organised retailers in India, or e-commerce in Indonesia, and then investing in the right companies. 2022 will certainly be no different, find the right companies, and it should be a rewarding year.

By Rob Brewis, fund manager for the Aubrey Global Emerging Market strategy.


bottom of page